APA (7th ed.) Citation

ST, W., CI, R., I, G. C., AD, S., YV, S., JA, R., . . . U, R. (2023). Effects of prenatal docosahexaenoic acid supplementation on offspring cardiometabolic health at 11 years differs by maternal single nucleotide polymorphism rs174602: Follow-up of a randomized controlled trial in Mexico. The American journal of clinical nutrition, 118(6), 1123. https://doi.org/10.1016/j.ajcnut.2023.10.005

Chicago Style (17th ed.) Citation

ST, Wimalasena, Ramirez-Silva CI, Gonzalez Casanova I, Stein AD, Sun YV, Rivera JA, Demmelmair H, Koletzko B, and Ramakrishnan U. "Effects of Prenatal Docosahexaenoic Acid Supplementation on Offspring Cardiometabolic Health at 11 Years Differs by Maternal Single Nucleotide Polymorphism Rs174602: Follow-up of a Randomized Controlled Trial in Mexico." The American Journal of Clinical Nutrition 118, no. 6 (2023): 1123. https://doi.org/10.1016/j.ajcnut.2023.10.005.

MLA (9th ed.) Citation

ST, Wimalasena, et al. "Effects of Prenatal Docosahexaenoic Acid Supplementation on Offspring Cardiometabolic Health at 11 Years Differs by Maternal Single Nucleotide Polymorphism Rs174602: Follow-up of a Randomized Controlled Trial in Mexico." The American Journal of Clinical Nutrition, vol. 118, no. 6, 2023, p. 1123, https://doi.org/10.1016/j.ajcnut.2023.10.005.